Plain-English translation of NCT06479187 on ClinicalTrials.gov ↗ · Source last updated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
United States
Phase
Post-approval monitoring
Sponsor
Brigham and Women's Hospital
Collaborators
Dana-Farber Cancer Institute, Blue Earth Diagnostics
Enrollment target
~20 participants
Started
June 2024
Primary completion
December 2026
Age range
18 Years and older
Sex
Male only
Last updated on clinicaltrials.gov in October 2026.